Identification of tumor suppressive miRNAs induced by histone deacetylase inhibitor vorinostat in human breast cancer cells
| Project/Area Number |
22791263
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
General surgery
|
|---|
| Research Institution | Kansai Medical University |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2010 – 2011
|
| Project Status |
Completed (Fiscal Year 2011)
|
| Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2011: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2010: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
|
|---|
| Keywords | HDAC / inhibitor / microRNA / breast cancer / HDAC inhibitor / vorinostat / tumor suppressor |
|---|
| Research Abstract |
Vorinostat is a histone deacetylase inhibitor that effectively suppresses cancer-cell proliferation by inducing cell-cycle arrest and/or apoptosis. Emerging evidence suggests that aberrant expression of microRNAs(miRNAs), single-strand RNAs of 18-24 nt express endogenously, plays pivotal roles in cancer pathogenesis. The aim of the present study was to identify tumor suppressive miRNAs through comparison of miRNA expression profiles of MDA-MB-231 cells treated with/without vorinostat using PCR-based miRNA array system. We identified 18 miRNAs, which were significantly up-regulated after 24 h treatment with vorinostat. In addition, four up-regulated and three down-regulated miRNAs were also identified after 48 h treatment with vorinostat. Among these miRNAs, four of them were persistently up-regulated for up to 48 h after vorinostat treatment. These miRNAs may be useful as a molecular target for breast cancer therapy or a diagnosis marker.
|
Report
(3 results)
Research Products
(13 results)
